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Introduction: Gestational diabetes mellitus (GDM) is the impaired glucose tolerance that is recognized first time 
during pregnancy. When a woman gets pregnant, glucose intolerance increases and manifests as a positive GDM 
diagnosis. It has been considered a transient condition because after delivery the majority of cases return to 
normoglycemic levels.  
Materials and Methods: This cross-sectional study was conducted in the Department of Obstetrics and 
Gynecology, Rawal Institute of Health Sciences, Islamabad. Data were collected in a period of 06 months between 
July 2020 to January 2021. A total of 100 women were included in the study and 5cc of their blood was taken from 
the vein under aseptic measures for measuring serum triglyceride levels after 12 hours of overnight fasting. Data 
were analyzed in SPSS version 20.0.   
Results: The overall mean Serum Triglyceride level of study subjects was 181.17±33.62 mg/dl, with a range of 
151-359 mg/dl. Around two-third, 66% of women had <181 mg/dl of Serum Triglyceride level, and 34% of 
patients had it >181 mg/dl. Our observation was that the mean level of Serum Triglyceride was not different 
significantly among age, BMI, gestational age, educational and socio-economic groups with p-value >0.05. 
Conclusion: This study highlights that the circulating mean triglyceride level in GDM subjects was significantly 
elevated from the normal pregnancy levels.   
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Introduction 
 
The new onset of glucose intolerance in pregnancy is 
called GDM.1 During the second half of pregnancy 
placental hormones like HPL, progesterone, cortisol, 
prolactin, and TNF-alpha oppose the insulin effect 
leading to insulin resistance. This increases the insulin 
required creating, a diabetogenic, environment.2 In 
other words we can say a combination of pancreatic 
beta-cell insufficiency, insulin resistance with genetic 
factors manifest as GDM. As in most cases, 
postpartum blood sugar levels become normal, GDM 
is considered a 'transient condition'. However, 
mounting evidence suggests that GDM should be 
viewed more as a marker for chronic disease.  
GDM affects 7% of all pregnancies in the US and 2-6% 
of pregnancies in Europe.3 Globally, prevalence 
estimates vary greatly depending on the population 
studied and the diagnostic test used, from1% among 
Nigerian women to 19% among women of Chennai, 
India.4 Several studies also indicated is parities by 
race/ethnicity, with higher prevalence among 
minorities.5 GDM rates are increasing, with a100% 
increase in incidence for some ethnic groups compared 
to 20 years ago.6 This reflects the increasing incidence 
of obesity and diabetes even in non-pregnant women. 
GDM rates tend to follow T2DM rates, and both 
increased pre-pregnancy BMI and weight gain in 
adulthood are risk factors for GDM.7  
According to a recent systematic review report 
overweight women two times and obese women 
greater than three times are more likely to develop 
GDM when compared with normal weight women.8 
GDM is accompanied by alterations in pre and post-
meal and 24-hour plasma concentrations of glucose, 
lipids, and amino acids. Clark and colleagues reported 
that women with GDM have higher triglycerides, free 
fatty acids, and beta hydroxyl butyrate and lower 
high-density lipoprotein (HDL) cholesterol than 
normal pregnant subjects.9 
In one of the study the mean triglycerides (TG) level 
was found to be 1.83 ± 0.10 mmol/L and the total 
cholesterol was 5.71 ± 0.24 mmol/L.10 In another study 
TG was found to be 216.20 ± 15.18 gm/dl in women 
with gestational diabetes mellitus. Therefore, women 
with GDM are at greater risk for developing 
hypertension, hyperlipidemia, and electrocardiogram 
abnormalities.11 
The rationale of the study was to estimate the level of 
TG in GDM cases as local data is scarce on this topic. 
The aim was to determine the mean level of TG in 
women with GDM presenting to a tertiary care 
hospital. 
  
Materials and Methods 
 
This cross-sectional study was conducted in the 
Department of Obstetrics and Gynaecology, Rawal 
Institute of Health Sciences, Islamabad. A total of 100 
pregnant women were enrolled in a period of 6 
months from July 2020 to January 2021.  
The women between 25-35 years of age, those with 
gestational age >12 weeks (on dating scan), with 
singleton pregnancy confirmed on ultrasound, having 
parity <3 and BMI levels of < 30 kg/m2 were included 
in the study. Those women with known DM, 
hypertension, heart disease, or chronic renal disease 
were excluded from the study. Women were also 
excluded if they had a prior history of lipid disorder or 
metabolic syndrome, were suffering from thyroid 
diseases, liver diseases, and those women who were 
taking medications that alter lipid metabolism.  
Women attending the outpatient departments of 
Obstetrics and Gynaecology departments were 
enrolled. Written informed consent was taken from 
women prior to enrollment. Demographic 
characteristics as age, gestational age, and BMI were 
noted. Moreover, educational status and 
socioeconomic status were also noted. 
Women's 5cc blood was taken from the vein under 
aseptic measures for testing TG level after 12 hours 
overnight fast and the findings of serum TG levels 
were noted.  
SPSS version 20 for Windows was used for data 
analysis. Mean± SD was measured for the age of the 
patient, TG levels, gestational age, height, weight, and 
BMI. Frequency and percentage were presented for 
qualitative data like Parity, educational status, and 
economic status. Stratification was done for TG levels 
<181 mg/dl and >181 mg/dl. The sociodemographic 
characteristics and gestational history parameters of 
women were associated with TG categories using t-test 
for age, gestational age, and BMI and ANOVA for 
Education and socioeconomic status. A p-value less 
than or equal to 0.05 was taken as significant.  
Sample size: Mean ± SD of TG level in women with 
GDM= 1.83±0.10 mmol/L 
  Confidence Level (C.L) = 95% 
  Absolute precision (d) = 0.05% 
Sample size (n) = 15, considering stratification the 
sample size increased to 100 women with GDM on 
diet control  
Sampling technique: Non-probability consecutive 
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Results 
 
A total of 100 women were evaluated to determine the 
mean level of triglycerides level (TG) in women with 
Gestational Diabetes Mellitus. The overall mean age of 
study subjects was 28.39 ± 2.05 years, with a range of 8 
(25-33) years. There were 55% patients of <28 years of 
age and 45% patients were >28 years. The overall 
mean weight was 42.05 ± 6.55 Kg, with a range of 33 to 
69 Kg. The overall mean height was 154.18 ± 10.73 cm, 
with a range of 142 to 173cm. The socio-economic 
status was also assessed and it was observed that 38% 
of patients belonged to the poor class, 47% of patients 
belonged to the lower middle class and 15% of patients 
belonged to the upper middle class. (Table 1) 
The overall mean gestational age was 29.1 ± 2.1 weeks, 
with a range of 24 to 34 weeks. The average parity was 
2.17 ± 0.79 with a range of 1 to 3. The overall mean 
BMI was 17.73 ± 2.30 Kg/m2 with a range of 14.3 to 
23.1 Kg/m2. The educational status was assessed, 
results showed that 2 patients were illiterate, 12 
patients got education till primary, 20 patients had 
done matric and 66 patients had an education level of 
intermediate or above. (Table 2)  
The overall mean Serum Triglyceride level of study 
subjects was 182.3 ± 32.6 mg/dl, ranging from 151 to 
359 mg/dl. There were 66% patients with triglyceride 
levels ≤ 181 mg/dl and 34% patients with >181 mg/dl. 
(Table 3) 
Furthermore, the mean triglyceride levels were 
stratified according to the socio-demographic 
characteristics of patients. A post-stratification t-test 
was applied to evaluate a significant difference in 
mean Serum Triglyceride level between age, 
gestational age, and BMI groups. ANOVA was 
applied to evaluate the significant difference of mean 
Serum Triglyceride level between educational and 
socio-economic status. There was no significant 
variation in triglyceride levels according to age, BMI, 
education, and socioeconomic status of patients. 
However, higher gestational age was found 
significantly associated with an increased level of 
serum triglyceride in women (p-value, 0.04). (Table 4) 
Table 1: Baseline characteristics of patients (n=100) 
 No of cases %age 
Age categories   
   < 25 55 55.0% 
   > 25 45 45.0% 
Mean ± SD 28.39 ± 2.06  
Weight (kg)   
  Mean ± SD 42.05 ± 6.55  
Height (cm)   
  Mean ± SD 154.18 ± 10.73  
Socioeconomic status   
  Poor class 38 38.0% 
  Lower middle class 47 47.0% 
  Upper middle class 15 15.0% 
 
Table 2: Gestational history, BMI, and educational 
level of patients (n=100) 
 No of cases %age 
Gestational age (weeks)   
Mean ± SD 29.12 ± 2.10  
Parity   
  Mean ± SD 2.17 ± 0.79  
BMI (kg/m2)   
  Mean ± SD 17.73 ± 2.30  
Educational status   
  Illiterate/primary 14 14.0% 
  Matric 20 20.0% 
  Intermediate or more 66 66.0% 
 
Table 3: Overall Serum Triglyceride Levels in the 
Study (n=100) 
 No. of cases %age 
Triglycerides   
< 181 mg/dl 66 66.0% 
181 or above 34 34.0% 
Mean ± SD 182.5 ± 36.4  
Table 4: Stratified analysis of Triglyceride levels 
according to sociodemographic characteristics of 
study patients (n=100) 
 Triglycerides 
(mg/dl) 
(Mean ± SD) 
p-
value 
Age (years)   
  < 28 years  183.0 ± 28.7 0.88 
  > 28 years 182.3 ± 39.6 
Gestational age (weeks)   
   < 30 176.4 ± 23.1 0.04 
   > 30 190.3 ± 47.5 
BMI   
  < 18 178.8 ± 25.7 0.15 
  > 18 187.4 ± 46.9 
Education   
  Illiterate/primary 172.67 ± 16.946 0.35 
  Matriculate 175.42 ± 15.565 
  Intermediate or above 184.97 ± 39.449 
Socioeconomic status   
  Poor class 188.24 ± 41.915 0.15 
  Lower middle class 183.00 ± 35.848 
  Upper middle class 166.93 ± 13.440 
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Discussion 
 
Women with GDM are at high risk of maternal and 
fetal complications during pregnancy.  
Abnormal maternal metabolism affects the growth of 
the fetus, because diabetes produces changes in 
maternal metabolic fuels and because diabetic 
pregnancy is often associated with complications, the 
effects of maternal diabetes on lipid metabolism are 
unclear.12 
In the current study, the triglycerides (TG) levels were 
found higher with a mean value of 181.18 ± 33.62 
mg/dl. These results confirmed the previous results 
reviewed for lipidemia of pregnancy.13 There is 
Hyperlipidemia in normal pregnancy and consisting 
of main triglycerides with smaller rises in cholesterol. 
Triglycerides level was studied in normal and GDM 
pregnancies by Ren Z et al and results reported to 
show a trend towards being higher in diabetic 
patients.14 Their results showed that the mean serum 
triglycerides concentration for the GDM (2.29 ± 
0.074mmol/L) was statistically significantly higher 
(p<0.001) than controls (1.75 ± 0.083mmol/L). In this 
study results, there was also an elevation of 
triglycerides level in GDM cases which is consistent 
with results reported by many investigators.  
The current study revealed that women who had 
GDM had a prevalence rate (34%) of high triglyceride 
levels. Increased TG during pregnancy occurs due to 
enhanced hepatic production of very-low-density 
lipoprotein (VLDL) under the effect of high estrogen.15 
In addition, intestinal absorption of dietary lipid is 
increased while TG clearance is reduced due to 
decreased extrahepatic lipoprotein lipase activity. 
These changes coincide with reduced insulin 
sensitivity, which may also contribute to the increase 
in TG levels.16 This hyperlipidemia including 
hypertriglyceridemia is pronounced in GDM 
pregnancies.17 Maternal insulin sensitivity has a 
negative association with newborn birthweight.18  
Elevated triglyceride levels are also suggestive of 
overall elevated risk of cardiovascular disease in 
women with a history of GDM. Women with prior 
GDM are known to have a higher prevalence of 
cardiovascular disease and occurrence of CVD events 
at a younger age.19,20 
One study shows that there is a link between women 
GDM or a family history of type 2 diabetes mellitus 
and their CVD risk. Results from this study showed 
that women were at a significantly increased risk of 
developing CVD at a young age. The researchers 
recommended that cardiovascular interventions 
should be considered in this group before the advent 
of disease in order to  reduce or prevent the risk of 
CVD.20 Studies in other populations have  identified 
risk factors for cardiovascular disease such as 
hypertension,  central obesity, and atherosclerosis, and 
type 2 diabetes mellitus to be  increased in women 
with prior GDM.21 
Maternal factors such as BMI (body mass index), 
maternal weight, gestational age, pre-pregnancy lipid 
levels, and various medical complications of 
pregnancy may also have significant effects on lipid 
metabolism and plasma lipid levels.22 In this study, it 
was observed that triglyceride level was significantly 
elevated in lower gestational age. This agreed with a 
study by Amraei and Azemati who reported a 
significant increase in the concentration of 
triglycerides levels in pregnancy complicated by 
glucose intolerance as compared to normal 
pregnancy.23 
The advantages of the study lie in the fresh evidence 
on women with gestational diabetes mellitus and its 
effect on triglyceride levels. There were some potential 
limitations of this study. Firstly, there was a short 
follow-up period which consisted of one GDM review 
for each patient. This aspect of our study may have 
affected our results due to existing evidence that the 
prevalence rate of GDM complications increases with 
time. In addition, we did not have access to a patient’s 
pre-pregnancy medical history and it is possible that 
some women had pre-existing diabetes and did not 




The study highlights and validated that serum 
triglyceride levels are significantly high in women 
with GDM. The mean triglyceride level was found 
more raised in women with high BMI and advanced 
gestational age. Since the sample was small scale and 
the study was conducted in an urban setting, the 
results cannot be generalized. Further large-scale trials 
in different geographical locations and with rigorous 
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